Simultaneous estimation of amlodipine and atenolol in human plasma: A sensitive LC-MS/MS method validation and its application to a clinical PK study

Bioanalysis

Volumn 5, Issue 7, 2013, Pages 827-837

  Kallem, Raja Reddy ^a   Mullangi, Ramesh ^b   Hotha, Kishore Kumar ^c,d   Ravindranath, Lk ^c   Spoorthy, Yn ^c   Seshagirirao, Jvln ^e  

^a ANDHRA UNIVERSITY   (India)

^b JUBILANT BIOSYS LTD   (India)

^c SRI KRISHNADEVARAYA UNIVERSITY   (India)

^d Novel Laboratories Inc   (United States)

^e Yalamarty Pharmacy College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPIN AT; AMLODIPINE; AMLODIPINE PLUS ATENOLOL; ATENOLOL; UNCLASSIFIED DRUG;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; DRUG RETENTION; DRUG STABILITY; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN EXPERIMENT; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PLASMA CONCENTRATION-TIME CURVE; SENSITIVITY AND SPECIFICITY; TIME TO MAXIMUM PLASMA CONCENTRATION; VALIDATION PROCESS;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ATENOLOL; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, LIQUID; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84875709954     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.39     Document Type: Article

References (32)

1. Sarafidis PA, Bakris GL. State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension. J. Clin. Hypertens. 10(2), 130-139 (2008).
2. Ong KL, Cheung BMY, Man YB et al. Prevalence, awareness, treatment, and control of hypertension among United States adults, 1999-2004. Hypertens. 49(1), 69-75 (2007).
3. Frank J. Managing hypertension using combination therapy. Am. Fam. Physician 77(9), 1279-1286 (2008).
4. Stanton T, Reid JL. Fixed dose combination therapy in treatment of hypertension. J. Hum. Hypertens. 16(2), 75-78 (2002).
5. Beresford AP, McGibney D, Humphrey MJ, Macrae PV, Stopher DA. Metabolism and kinetics of amlodipine in man. Xenobiotica 18(2), 245-254 (1988).
6. Kirch W, Görg KG. Clinical PKs of atenolol - a review. Eur. J. Drug Metab. Pharmacokinet. 7(2), 81-91 (1982).
7. Mettimano M, Pichetti F, Fazzari L et al. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension. Int. J. Clin. Pract. 54(7), 424-428 (2000)
8. Pareek A, Salkar H, Mulay P, Desai S, Chandurkar N, Redkar N. A randomized, comparative, multicentric evaluation of atenolol/amlodipine combination with atenolol alone in essential hypertensive patients. Am. J. Ther. 17(1), 46-52 (2010).
9. Yasuda T, Tanaka M, Iba K. Quantitative determination of amlodipine in serum by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. J. Mass Spectrom. 3(8), 879-884 (1996).
10. Chen XY, Luan Y, Zhong DF, Du ZM. Determination of amlodipine in human plasma by liquid chromatography-tandem mass spectrometry Yao Xue Xue Bao 36(1), 51-54 (2001).
11. Feng Y, Zhang L, Shen Z, Pan F, Zhang Z. Analysis of amlodipine in human plasma by liquid chromatography-mass spectrometry. J. Chromatogr. Sci. 40(1), 49-53 (2002).
12. Massaroti P, Moraes LA, Marchioretto MA et al. Development and validation of a selective and robust LC-MS/MS method for quantifying amlodipine in human plasma. Anal. Bioanal. Chem. 382(4), 1049-1054 (2005).
13. Nirogi RV, Kandikere VN, Mudigonda K, Shukla M, Maurya S. Sensitive and rapid liquid chromatography/tandem mass spectrometry assay for the quantification of amlodipine in human plasma. Biomed. Chromatogr. 20(9), 833-842 (2006).
14. Bhatt J, Singh S, Subbaiah G, Shah B, Kambli S, Ameta S. A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of amlodipine in human plasma. Biomed. Chromatogr. 21(2), 169-175 (2007).
15. Ma Y, Qin F, Sun X, Lu X, Li F. Determination and PK study of amlodipine in human plasma by ultra performance liquid chromatography-electrospray ionization mass spectrometry. J. Pharm. Biomed. Anal. 43(4), 1540-1545 (2007).
16. Zou Q, Zhan Y, Ge Z, Wei P, Ouyang P. Liquid chromatography-mass spectrometry method for the determination of amlodipine in human plasma and its application in a bioequivalence study. Arzneimittelforschung 59(8), 383-391 (2009).
17. Li W, Li Y, Francisco DT, Naidong W. Hydrophilic interaction liquid chromatographic tandem mass spectrometric determination of atenolol in human plasma. Biomed. Chromatogr. 19(5), 385-393 (2005).
18. Johnson RD, Lewis RJ. Quantitation of atenolol, metoprolol and propranolol in postmortem human fluid and tissue specimens via LC/APCI-MS. Forensic Sci. Int. 156(2-3), 106-117 (2006).
19. Li S, Liu G, Jia J et al. Simultaneous determination of ten antiarrhythic drugs and a metabolite in human plasma by liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 847(2), 174-181 (2007).
20. Gonzalez O, Iriarte G, Rico E et al. LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 878(28), 2685-2692 (2010).
21. Minamide Y, Osawa Y, Nishida H, Igarashi H, Kudoh S. A highly sensitive LC-MS/MS method capable of simultaneously quantitating celiprolol and atenolol in human plasma for a cassette cold-microdosing study. J. Sep. Sci. 34(13), 1590-1598 (2011).
22. Kallem RR, Inamadugu JK, Ramesh M, Seshagirirao JV. Sensitive LC-MS/MS-ESI method for simultaneous determination of nifedipine and atenolol in human plasma and its application to a human PK study. Biomed. Chromatogr. 27(3), 349-355 (2013).
23. Sarkar AK, Ghosh D, Das A et al. Simultaneous determination of metoprolol succinate and amlodipine besylate in human plasma by liquid chromatography-tandem mass spectrometry method and its application in bioequivalence study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 873(1), 77-85 (2008).
24. Ramani AV, Sengupta P, Mullangi R. Development and validation of a highly sensitive and robust LC-ESI-MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: application to a clinical PK study. Biomed. Chromatogr. 23(6), 615-622 (2009).
25. Shah S, Asnani A, Kawade D, Dangre S, Arora S, Yende S. Simultaneous quantitative analysis of olmesartan, medoxomil and amlodipine besylate in plasma by high-performance liquid chromatography technique. J. Young Pharm. 4(2), 88-94 (2012).
26. Chang H, Li J, Li J et al. Simultaneous determination of amlodipine and bisoprolol in rat plasma by liquid chromatography/tandem mass spectrometry method and its application in PK study. J. Pharm. Biomed. Anal. 71, 104-110 (2012).
27. Pilli NR, Inamadugu JK, Mullangi R, Karra VK, Vaidya JR, Rao JV. Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human PK study. Biomed. Chromatogr. 25(4), 439-449 (2011).
28. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation. FDA, Rockville, MD, USA (2001).
29. Viswanathan CT, Bansal S, Booth B et al. Quantitative bioanalytical methods validation and implementation: best practices for chromatographic and ligand binding assay. AAPS J. 9(1), E30-E42 (2007).
30. Rigby JW, Scott AK, Hawksworth GM, Petrie JC. A comparison of the PKs of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subject. Br. J. Clin. Pharmac. 20(4), 327-331 (1985).
31. European Medicines Agency. Guideline on Validation of Bioanalytical Methods.www.ema.europa.eu/ema
32. Norvasc data sheet.www.medsafe.govt.nz/profs/datasheet/n/Norvasctab.pdf